A survey by benefits consultant Mercer found 49% of large employers covered GLP-1 medications for obesity in 2025, up from 41% in 2023
Understanding Insurance Coverage for Weight Loss Medications When it comes to getting weight loss drugs covered by insurance, the first thing to understand is that coverage variessometimes significantlydepending on your specific health plan and the medication in question
The term "GLP-1 balance" is not a formal medical diagnosis or standard clinical term used by healthcare professionals, but rather a lay concept describing the body's ability to produce, secrete, and respond to appropriate levels of this hormone in response to food intake and metabolic demands
Not everyone needs to pinch
Tirzepatide (MOUNJARO) is a once-weekly subcutaneous injectable agent first authorized for T2DM and later extended to the management of obesity or overweight with at least one weight-related comorbidity, thereby aligning its therapeutic scope with subcutaneous liraglutide and semaglutide [34,35,36]
We monitor patients regularly and adjust protocols based on response